The forensic genomics group at Illumina is now Verogen.

Introducing the world’s first sequencing company solely dedicated to forensic science.
Massively Parallel Sequencing – The Time Is Now

Hear from experts in the field how this technology is paving the way ahead and why now is the time to adopt.

Seq and You
Shall Find

Unlock the power of massively parallel sequencing (MPS) for forensic applications

Focused Forensic

The MiSeq FGx Forensic Genomics System is the first fully validated, Massively Parallel Sequencing (MPS) solution designed for forensic science.

previous arrow
next arrow

Verogen serves those who pursue the truth using genetic tools. It’s about advancing massively parallel sequencing to help unlock the true potential of forensic genomics. Supporting labs with innovative solutions and expert service purpose-built for the challenges of human identification. And, ultimately, to improve public safety and global justice for all.

Overcome Limitations. Solve More Cases.

In forensic laboratories worldwide, challenging DNA samples frequently require multiple interrogations to extract usable data. If the attempts are unsuccessful, valuable evidence and resources are consumed and cases remain unsolved.

The MiSeq FGx™ Forensic Genomics System harnesses the power of Illumina’s gold standard sequencing by synthesis (SBS) technology to analyze hundreds of forensically relevant markers (STRs and SNPs) in a single interrogation.

Now forensic examiners can develop more detailed profiles from degraded, mixed, and limited biological evidence samples, addressing a wider range of questions in a single, targeted assay.

The Evidence Speaks For Itself.

“The formation of Verogen is exciting as it demonstrates a greater commitment to focused development and support of forensic applications for massively parallel sequencing.”

Bruce Budowle

Lab Director, UNT

“The advantage of the MiSeq for us is its versatility. We’re able to look at so many applications at the same time, whether it be methylation for age prediction, metagenomics, or normal sequencing of STRs that we would use in a traditional crime scene case”

David Ballard

Forensic Scientist

“It was very obvious that massively parallel sequencing could provide a much deeper insight into the true nature of complex mixtures, especially in terms of picking up minor contributions”

Peter de Knijff

Forensic Geneticist

Learn more about how Verogen’s technology can unlock the power of MPS for forensic genomics applications.

News & Events

AAFS 2018 Highlights from Verogen

The increasing interest in using massively parallel sequencing (MPS) for forensic genomics applications was palpable at the recent American Academy of Forensic Sciences (AAFS) 70th Annual Scientific Meeting held in Seattle, WA, February 19-24th. This was evident not...

read more

Support & Resources

Knowledge Center
Technical Resources
Contact Us

Sign Up To Stay Informed

Be the first to receive the latest company updates, a preview of upcoming Verogen events and insights from key opinion leaders in forensic genomics by completing this brief form. We look forward to connecting.